FDA Offers Advice on Safe Dosing Practices for Diabetes Medications

FDA Offers Advice on Safe Dosing Practices for Diabetes Medications

The U.S. Food and Drug Administration (FDA) has issued a warning to both patients and healthcare providers regarding dosing errors associated with compounded versions, NOT the genuine manufactured product, of Novo Nordisk’s weight-loss and diabetes drugs,...
Are Current Surgical Fasting Guidelines Adequate for Diabetic Patients?

Are Current Surgical Fasting Guidelines Adequate for Diabetic Patients?

Recent research suggests that people with diabetes do not need to fast longer before surgery compared to those without diabetes. This study, led by a team of anesthesiologists, found no significant difference in gastric volumes between diabetic and non-diabetic...
Mounjaro Takes the Lead Over Ozempic

Mounjaro Takes the Lead Over Ozempic

A new study reveals that Eli Lilly’s Mounjaro significantly outperforms Novo Nordisk’s Ozempic in promoting weight loss, despite both drugs sharing similar side effects and dropout rates.Key FindingsThe research, published in JAMA Internal Medicine,...
Facebook
Instagram